Regulation of Toll-like receptors-mediated inflammation by immunobiotics in bovine intestinal epitheliocytes: Role of signalling pathways and negative regulators

Frontiers in Immunology

Volumn 5, Issue AUG, 2014, Pages

  Villena, Julio ^a,b   Aso, Hisashi ^c   Kitazawa, Haruki ^c  

^a Immunobiotics Research Group ^*  (Argentina)

^b CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Bifidobacteria; Bovine intestinal epitheliocytes; Immunobiotics; Inflammation; Intestinal immunity; Lactobacilli; TLR negative regulators; TLR4

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBIOTIC AGENT; PROTEIN BCL 3; TOLL LIKE RECEPTOR; CYCLOOXYGENASE 2; GLOBOTRIAOSYLCERAMIDE; GLOBOTRIAOSYLCERAMIDE GB3; IMMUNOBIOTIC AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; PATTERN RECOGNITION RECEPTOR; RANTES; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VEROTOXIN;

BACTERIUM ADHERENCE; CELL DISRUPTION; CELL INTERACTION; CELL INVASION; ENZYME ACTIVATION; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOREGULATION; INTESTINE EPITHELIUM CELL; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; UPREGULATION; BIFIDOBACTERIUM; CATTLE; ECONOMIC ASPECT; ENTERITIS; GASTROINTESTINAL DISEASE; HOST; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INTESTINAL EPITHELIOCYTE; INTRACELLULAR SIGNALING; LACTOBACILLUS; PATHOGENESIS; REGULATORY MECHANISM;

EID: 84919418965     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00421     Document Type: Review

References (82)

1. Yen TH, Wright NA: The gastrointestinal tract stem cell niche. Stem Cell Rev 2006, 2:203-212.
2. Wells JM, Rossi O, Meijerink M, van Baarlen P: Epithelial crosstalk at the microbiota mucosal interface. Proc Natl Acad Sci USA 2011, 108:4607-4614.
3. Villena J, Kitazawa H: Modulation of intestinal TLR4-inflammatory signalling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937. Front Immunol 2014, 4(512):1-12.
4. Marco ML, Pavan S, Kleerebezem M: Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 2006, 17:204-210.
5. Clancy R: Immunobiotics and the probiotic evolution. FEMS Immunol Med Microbiol 2003, 38:9-12.
6. Lebeer S, Vanderleyden J, De Keersmaecker CJ: Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 2010, 8:171-184.
7. Bridger PS, Mohr M, Stamm I, Fröhlich J, Föllmann W, Birkner S, Metcalfe H, Werling D, Baljer G, Menge C: Primary bovine colonic cells: a model to study strain-specific responses to Escherichia coli. Vet Immunol Immunopathol 2010, 137:54-63.
8. Dibb-Fuller MP, Best A, Stagg DA, Cooley WA, Woodward MJ: An in-vitro model for studying the interaction of Escherichia coli O157:H7 and other enteropathogens with bovine primary cell cultures. J Med Microbiol 2001, 50:759-769.
9. Föllmann W, Birkner S: The use of cultured primary bovine colon epithelial cells as a screening model to detect genotoxic effects of heterocyclic aromatic amines in the comet assay. J Toxicol Environ Health 2008, 71:947-953.
10. Hoey DEE, Sharp L, Currie C, Lingwood CA, Gally DL, Smith DGE: Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity. Cell Microbiol 2003, 5:85-97.
11. Rusu D, Loret S, Peulen O, Mainil J, Dandrifosse G: Immuno-chemical, biomolecular and biochemical characterization of bovine epithelial intestinal primocultures. BMC Cell Biol 2005, 6:42
12. Baskaran S, Venkitanarayana A: Plant-derived antimicrobials reduce E. coli O157:H7 virulence factors critical for colonization in cattle gastrointestinal tract in vitro. Biomed Res Int 2014, In press.
13. Gaggìa F, Mattarelli P, Biavati B: Probiotics and prebiotics in animal feeding for safe food production. Int J Food Microbiol 2010, 141:S15-28.
14. Fujie H, Villena J, Tohno M, Morie K, Simazu T, Aso H, Suda Y, Iwabuchi N, Xiao J, Iwatsuki K, Kawai Y, Saito T, Kitazawa H: Toll-like receptor-2 activating bifidobacteria strains differentially regulate inflammatory cytokines in porcine intestinal epithelial cell culture system: finding new anti-inflammatory immunobiotics. FEMS Immunol Med Microbiol 2011, 63:129-139.
15. Shimazu T, Villena J, Tohno M, Fujie H, Hosoya S, Shimosato T, Aso H, Suda Y, Kawai Y, Saito T, Makino S, Ikegami S, Itoh H, Kitazawa H: Immunobiotic Lactobacillus jensenii elicit anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the toll- like receptor signaling pathway. Infect Immun 2012, 80:276-288.
16. Villena J, Suzuki R, Fujie H, Chiba E, Takahashi T, Shimazu T, Aso H, Ohwada S, Suda Y, Ikegami S, Itoh H, Alvarez S, Saito T, Kitazawa H: Immunobiotic Lactobacillus jensenii modulates toll-like receptor 4-induced inflammatory response via negative regulation in porcine antigen presenting cells. Clin Vaccine Immunol 2012, 19:1038-1053.
17. Maldonado NC, De Ruiz SC, Otero MC, Sesma F, Nader-Macías ME: Lactic acid bacteria isolated from young calves -Characterization and potential as probiotics. Res Vet Sci 2012, 92:342-349.
18. Miyazawa K, Hondo T, Kanaya T, Tanaka S, Takakura I, Itani W, Rose MT, Kitazawa H, Yamaguchi T, Aso H: Characterization of newly established bovine intestinal epithelial cell line. Histochem Cell Biol 2010, 133:125-134.
19. Takanashi N, Tomosada Y, Villena J, Murata K, Takahashi T, Chiba E, Tohno M, Shimazu T, Aso H, Suda Y, Ikegami S, Itoh H, Kawai Y, Saito T, Alvarez S, Kitazawa H: Advanced application of bovine intestinal epithelial cell line for evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia coli-mediated inflammation. BMC Microbiol 2013, 13:54
20. Lee JD, Mo JH, Shen C, Rucker AN, Raz E: Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis. Curr Opin Gastroenterol 2007, 23:27-31.
21. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK: Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 2000, 164:966-972.
22. Sitaraman SV, Merlin D, Wang L, Wong M, Gewirtz AT, Si- Tahar M, Madara JL: Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest 2001, 107:861-869.
23. Warhurst AC, Hopkins SJ, Warhurst G: Interferon gamma induces differential up regulation of alpha and beta chemokine secretion in colonic epithelial cell lines. Gut 1998, 42:208-213.
24. Berkes J, Viswanathan VK, Savkovic SD, Hecht G: Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 2003, 52:439-451.
25. Kitazawa H, Villena J: Modulation of respiratory TLR3-antiviral response by probiotic microorganisms: lessons learned from Lactobacillus rhamnosus CRL1505. Front Immunol 2014, 5(201):1-15.
26. Salva S, Villena J, Alvarez S: Diferential immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections. Int J Food Microbiol 2010, 141:82-89.
27. Villena J, Racedo S, Agüero G, Bru E, Medina M, Alvarez S: Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr 2005, 135:1462-1469.
28. Maldonado NC, de Ruiz CS, Otero MC, Sesma F, Nader-Macías ME: Lactic acid bacteria isolated from young calves--characterization and potential as probiotics. Res Vet Sci 2012, 92:342-349.
29. Nader-Macías ME, Otero MC, Espeche MC, Maldonado NC: Advances in the design of probiotic products for the prevention of major diseases in dairy cattle. J Ind Microbiol Biotechnol 2008, 35:1387-1395.
30. Signorini ML, Soto LP, Zbrun MV, Sequeira GJ, Rosmini MR, Frizzo LS: Impact of probiotic administration on the health and fecal microbiota of young calves: a meta analysis of randomized controlled trials of lactic acid bacteria. Res Vet Sci 2012, 93: 250-258.
31. Abe F, Ishibashi N, Shimamura S: Effect of administration of bifidobacteria and lactic acid bacteria to newborn calves and piglets. J Dairy Sci 1995, 78:2838-2846.
32. Mokhber-Dezfouli MR, Tajik P, Bolourchi M, Mahmoudzadeh H: Effects of probiotics supplementation in daily milk intake of newborn calves on body weight gain, body height, diarrhea occurrence and health condition. Pak J Biol Sci 2007, 10:3136-3140.
33. Zhao T, Tkalcic S, Doyle MP, Harmon BG, Brown CA, Zhao P: Pathogenicity of enterohemorrhagic Escherichia coli in neonatal calves and evaluation of fecal shedding by treatment with probiotic Escherichia coli. J Food Prot 2003, 66:924-930.
34. Tkalcic S, Zhao T, Harmon BG, Doyle MP, Brown CA, Zhao P: Fecal shedding of enterohemorrhagic Escherichia coli in weaned calves following treatment with probiotic Escherichia coli. J Food Prot 2003, 66:1184-1189.
35. Frizzo LS, Zbrun MV, Soto LP, Bertozzi E, Sequeira GJ, Marti LE, Signorini ML, Armesto RR, Rosmini MR: Pathogen translocation and histopathological lesions in an experimental model of Salmonella Dublin infection in calves receiving lactic acid bacteria and lactose supplements. J Vet Sci 2012, 13:261-270.
36. Haller D, Holt L, Parlesak A, Zanga J, Bauerlein A: Differential effect of immune cells on non-pathogenic Gram-negative bacteria-induced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells. Immunol 2004, 112:310-320
37. Bruno ME, Frantz AL, Rogier EW, Johansen FE, Kaetzel CS: Regulation of the polymeric immunoglobulin receptor by the classical and alternative NF-kappaB pathways in intestinal epithelial cells. Mucosal Immunol 2011, 4:468-478.
38. Andersen V, Christensen J, Ernst A: Polymorphisms in NF-?B, PXR, LXR, PPAR? and risk of inflammatory bowel disease. World J Gastroenterol 2011, 17:197-206.
39. O'Hara AM, O'Regan P, Fanning A, Mahony C, Macsharry J, Lyons A, Bienenstock J, O'Mahony F: Shanahan, Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunol 2006, 118:202-215.
40. Zhang L, Li N, Caicedo R, Neu J: Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr 2005, 135:1752-1756.
41. Lee JH, Lee B, Lee HS: Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis. Int J Colorectal Dis 2009, 24:231-223.
42. Liu Y, Fatheree NY, Mangalat N, Rhoads JM: Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-?B signaling in the intestine. Am J Physiol Gastrointest Liver Physiol 2012, 302:G608-G617.
43. Giahi L, Aumueller E, Elmadfa I, Haslberger AG: Regulation of TLR4, p38 MAPkinase, I?B and miRNAs by inactivated strains of lactobacilli in human dendritic cells. Benef Microbes 2012, 3:91-98.
44. Zhou C, Ma FZ, Deng XJ, Yuan H, Ma HS: Lactobacilli inhibit interleukin-8 production induced by Helicobacter pylori lipopolysaccharide-activated Toll-like receptor 4. World J Gastroenterol 2008, 14:5090-5095.
45. Tao Y, Drabik KA, Waypa TS, Musch MW, Alverdy JC, Schneewind O, Chang EB, Petrof EO: Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 2006, 290:C1018-1030.
46. Cheung PC, Campbell DG, Nebreda AR, Cohen P: Feedback control of the protein kinase TAK1 by SAPK2a/p38. EMBO J 2003, 22:5793-5805.
47. Muniyappa H, Das KC: Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK3-MKK7-dependent mechanism. Cell Signal 2008, 20:675-683.
48. Liew FY, Brint XD, EK O, Neill LA: Negative regulation of toll-like receptor- mediated immune responses. Nat Rev Immunol 2005, 5:446-458.
49. Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, Maschera B, Lewis A, Ray K, Tschopp J, Volpe F: Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol 2000, 2:346-351.
50. Zhang G, Ghosh S: Negative regulation of toll-like receptor- mediated signaling by Tollip. J Biol Chem 2002, 277:7059-7065.
51. Ibeagha-Awemu EM, Lee JW, Ibeagha AE, Bannerman DD, Paape MJ, Zhao X: Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells. Vet Res 2008, 39:11.
52. Fu Y, Liu B, Feng X, Liu Z, Liang D, Li F, Li D, Cao Y, Feng S, Zhang X, Zhang N, Yang Z: Lipopolysaccharide increases Toll-like receptor 4 and downstream Toll-like receptor signaling molecules expression in bovine endometrial epithelial cells. Vet Immunol Immunopathol 2013, 151:20-27.
53. Wessells J, Baer M, Young HA, Claudio E, Brown K, Siebenlist U, Johnson PF: Bcl-3 and NF-kB p50 attenuate lipopolysaccharide-induced inflammatoryresponses in macrophages. J Biol Chem 2004, 279:49995-50003.
54. Foster SL, Hargreaves DC, Medzhitov R: Gene-specific control of inflammation by TLR induced chromatin modifications. Nature 2007, 447:972-978
55. O'Mahony D, Murphy S, Boileau T, Park J, O'Brien J, Groeger G, Konieczna P, Ziegler M, Scully P, Shanahan F, Kiely B, O'Mahony L: Bifidobacterium animalis AHC7 protects against pathogen-induced NF-?B activation in vivo. BMC Immunol 2010, 11:63.
56. Malago JJL, Tooten PC, Koninkx JF: Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells. Benef Microbes 2010, 1:121-30.
57. Carey CM, Kostrzynska M: Lactic acid bacteria and bifidobacteria attenuate the proinflammatory response in intestinal epithelial cells induced by Salmonella enterica serovar Typhimurium. Can J Microbiol 2013, 59:9-17.
58. Roselli M, Finamore A, Britti MS, Konstantinov SR, Smidt H, de Vos WM, Mengheri E: The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage. J Nut 2007, 137(12):2709-2716.
59. Roselli M, Finamore A, Britti MS, Mengheri E: Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by Enterotoxigenic Escherichia coli K88. Brit J Nutr 2006, 95:1177-1184.
60. Bunešová V, Domig KJ, Killer J, Vlková E, Kopecny J, Mrázek J, Rocková S, Rada V: Characterization of bifidobacteria suitable for probiotic use in calves. Anaerobe 2012, 18:166-168.
61. Murata K, Villena J, Tomosada Y, Risa H, Chiba E, Shimazu T, Aso H, Suda Y, Iwabuchi N, Xiao J, Saito T, Kitazawa H: Bifidobacteria upregulate expression of toll-like receptor negative regulators counteracting enterotoxigenic Escherichia coli-mediated inflammation in bovine intestinal epitheliocytes. Open J Vet Med 2013, 3:143-155.
62. Vereecke L, Sze M, McGuire C, Rogiers B, Chu Y, Schmidt-Supprian M, Pasparakis M, Beyaert R, van Loo G: Enterocyte-specific A20 deficiency sensitizes to Tumor Necrosis Factor-induced toxicity and experimental colitis. J Exper Med 2010, 207:1513-1523.
63. Shibolet O, Podolsky DK: TLRs in the gut. IV. Negative regulation of Toll-Like receptors and intestinal homeostasis: addition by subtraction. Amer J Physiol Gastroint Liver Physiol 2007, 292(6):G1469-G1473.
64. Oshima N, Ishihara S, Rumi MA, Aziz MM, Mishima Y, Kadota C, Moriyama I, Ishimura N, Amano Y, Kinoshita Y: A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation. Clin Exp Immunol 2010, 159:185-198.
65. Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM, Beyaert R: Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB. J Cell Mol Med 2008, 12:316-329.
66. Verstrepen L, Carpentier I, Verhelst K, Beyaert R: ABINs: A20 binding inhibitors of NF Kappa B and apoptosis signaling. Bioch Pharmacol 2009, 78(2):105-111.
67. Xiao H, Gulen MF, Qin J, Yao J, Bulek K, Kish D, Altuntas CZ, Wald D, Ma C, Zhou H, Tuohy VK, Fairchild RL, de la Motte C, Cua D, Vallance BA, Li X: The Toll-Interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immun 2007, 26:461- 475.
68. Oshima N, Ishihara S, Rumi MA, Aziz MM, Mishima Y, Kadota C, Moriyama I, Ishimura N, Amano Y, Kinoshita Y: A20 Is an early responding negative regulator of Toll-Like receptor 5 signalling in intestinal epithelial cells during inflammation. Clin Exp Immunol 2010, 159(2):185-198.
69. Sugi Y, Takahashi K, Nakano K, Hosono A, Kaminogawa S: Transcription of the Tollip gene is elevated in intestinal epithelial cells through impaired O-GlcNA-cylation9 dependent nuclear translocation of the negative regulator Elf-1. Biochem Biophys Res Commun 2011, 412(4):704-709.
70. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, Baliga RS, Meng X, Smith CV, Bauer JA: MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J ExpMed 2006, 203(1):131-140.
71. Kohno M, Pouyssegur J: Targeting the ERK signaling pathway in cancer therapy. Ann Med 2006, 38(3):200-211.
72. Hartsough MT, Mulder KM: Transforming growth factor beta activation of p44MAPK in proliferating cultures of epithelial cells. J Biol Chem 1995, 270:7117-7124.
73. Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N: mTOR translation initiation and cancer. Oncogene 2006, 25:6416-6422.
74. Ben-Lulu S, Pollak Y, Mogilner J, Bejar J, G Coran A, Sukhotnik I: Dietary transforming growth factor-beta 2 (TGF-ß2) supplementation reduces methotrexate-induced intestinal mucosal injury in a rat. PLoS One 2012, 7:e45221.
75. Blanchette F, Rivard N, Rudd P, Grondin F, Attisano F, Dubois CM: Cross-Talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation. J Biol Chem 2001, 276:33986-33994
76. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N: Toll-Like receptor 2-mediated NF-Kappa B activation requires a Rac1-dependent pathway. Nat Immunol 2000, 1:533-540.
77. Fukao T, Tanabe M, Terauchi Y, Ota T, Matsuda S, Asano T: PI3K-Mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol 2002, 3:875-881.
78. Yu Y, Nagai S, Wu H, Neish AS, Koyasu S, Gewirtz AT: TLR5-mediated phosphoinositide 3-Kinase activation negatively regulates flagellin-induced proinflammatory gene expression. J Immunol 2006, 176(10):6194-6201.
79. Hoarau C, Martin L, Faugaret D, Baron C, Dauba A, Aubert-Jacquin C, Velge-Roussel F, Lebranchu Y: Supernatant from Bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells. PLoS One 2008, 3(7): e2753.
80. Otte JM, Podolsky DK: Functional modulation of enterocytes by Gram-positive and Gram-negative microorganisms. Amer J Physiol Gastrointest Liver Physiol 2004, 286(4):G613-G626.
81. Zeuthen LH, Fink LN, Frøkiaer H: Toll-Like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived Lactobacilli and Bifidobacteria in dendritic cells. Immunol 2008, 124(4):489-495.
82. Zanello G, Meurens F, Berri M, Chevaleyre C, Melo S, Auclair E, Salmon H: Saccharomyces cerevisiae decreases inflammatory responses induced by F4+ enterotoxigenic Escherichia coli in porcine intestinal epithelial cells. Vet Immunol Immunopathol 2011, 141(1-2):133-138.